Kazuichi Okazaki has been working in the field of gastroenterology and clinical immunology after he graduated from Kyoto University. After 5 years of clinical training and after a Ph.D. thesis, he started his academic career as an Assistant Professor at School of Medicine, Kochi University, in Japan. After he stayed for 2 years as a Visiting Researcher in New York Medical College and University of Medicine and Dentist of New Jersey, he was appointed as an Associate Professor at Kochi University in 1994. In 1996, he moved back to the Department of Gastroenterology, Kyoto University as Associate Professor. In 2003, he was nominated as Chairman and Professor at the Department of Gastroenterology and Hepatology, Kansai Medical University in Osaka. His main academic interest is in pancreatology and clinical immunology, especially autoimmune pancreatitis (AIP) as IgG4-related disease and inflammatory bowel disease. He has published more than 300 English articles in the filed of gastroenterology. He is Councilor of International Association of Pancreatology (IAP), Executive Councilors of Japan Pancreas Society (JPS), and Japanese Society of Gastroenterology (JSGE). He organized the committee for the Japanese Diagnostic Criteria for AIP in 2006 supported by JPS and contributed to make the International Consensus Diagnostic Criteria for AIP in 2010 supported by IAP. He has recently organized nationwide study groups in the filed of inflammatory bowel disease for developing novel therapies (from 2006 to 2009) and IgG4-related disease from the view of systemic sclerosing disease (from 2010 to 2013) supported by the Ministry of Labor, Health and Welfare of Japan. He has been invited as a Guest Speaker in the meetings held in Asia (Korea, Thailand, Taipei), Oceania (Australia), Europe (Italy), and the United States (APA, AGA).
Biography Updated on 1 June 2011